MX2017009681A - Composiciones dispersables. - Google Patents

Composiciones dispersables.

Info

Publication number
MX2017009681A
MX2017009681A MX2017009681A MX2017009681A MX2017009681A MX 2017009681 A MX2017009681 A MX 2017009681A MX 2017009681 A MX2017009681 A MX 2017009681A MX 2017009681 A MX2017009681 A MX 2017009681A MX 2017009681 A MX2017009681 A MX 2017009681A
Authority
MX
Mexico
Prior art keywords
compositions
dispersible compositions
useful
dispersible
pediatric
Prior art date
Application number
MX2017009681A
Other languages
English (en)
Inventor
Kumar Gupta Manish
Wasudeo MARATHE Shripad
Ramesh Tambwekar Kaustubh
Velayudhan NAIR Shreedevi
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2017009681A publication Critical patent/MX2017009681A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a composiciones dispersables que comprenden fumarato de bedaquilina como principio activo; tales composiciones son útiles en el tratamiento de tuberculosis y sus propiedades de dispersabilidad intrínsecas se prestan por sí mismas para ser útiles en particular entre la población pediátrica o geriátrica.
MX2017009681A 2015-01-27 2016-01-26 Composiciones dispersables. MX2017009681A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN264MU2015 2015-01-27
PCT/EP2016/051545 WO2016120258A1 (en) 2015-01-27 2016-01-26 Dispersible compositions

Publications (1)

Publication Number Publication Date
MX2017009681A true MX2017009681A (es) 2017-10-18

Family

ID=55229712

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009681A MX2017009681A (es) 2015-01-27 2016-01-26 Composiciones dispersables.

Country Status (29)

Country Link
US (2) US20180000810A1 (es)
EP (1) EP3250182B1 (es)
JP (3) JP7291458B2 (es)
KR (1) KR102631986B1 (es)
CN (2) CN114129526A (es)
AU (2) AU2016212116B2 (es)
CA (1) CA2973301A1 (es)
CY (1) CY1126107T1 (es)
DK (1) DK3250182T3 (es)
EA (1) EA201791701A1 (es)
ES (1) ES2948805T3 (es)
FI (1) FI3250182T3 (es)
HK (1) HK1243644A1 (es)
HR (1) HRP20230616T1 (es)
HU (1) HUE062481T2 (es)
IL (2) IL253626B2 (es)
LT (1) LT3250182T (es)
MA (1) MA41411B1 (es)
MD (1) MD3250182T2 (es)
MX (1) MX2017009681A (es)
PE (1) PE20171319A1 (es)
PH (1) PH12017501331A1 (es)
PL (1) PL3250182T3 (es)
PT (1) PT3250182T (es)
RS (1) RS64308B1 (es)
SG (1) SG11201705944TA (es)
SI (1) SI3250182T1 (es)
UA (1) UA126891C2 (es)
WO (1) WO2016120258A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
RS65207B1 (sr) 2017-07-14 2024-03-29 Janssen Pharmaceutica Nv Formulacije bedakvilina sa dugim delovanjem
WO2019193609A1 (en) * 2018-04-05 2019-10-10 Cipla Limited Pharmaceutical formulations
US11291654B2 (en) * 2018-09-13 2022-04-05 Syneurx International (Taiwan) Corp. Formulations of cycloserine compounds and applications thereof
WO2020123336A1 (en) * 2018-12-13 2020-06-18 Qrumpharma Inc. Compositions of bedaquiline, combinations comprising them, processes for their preparation, uses and methods of treatment comprising them
JP2022516671A (ja) * 2019-01-09 2022-03-01 ヤンセン ファーマシューティカ エヌ．ベー． 非結核性抗酸菌症の処置における組合せ
WO2021257461A1 (en) * 2020-06-15 2021-12-23 Mylan Laboratories Limited Combination antibacterial composition and method for antibacterial therapy
EP4164645A4 (en) * 2020-06-15 2024-07-10 The Global Alliance For Tb Drug Dev Inc ANTIBACTERIAL COMBINATION COMPOSITION AND ANTIBACTERIAL THERAPY METHOD
CN111888477B (zh) * 2020-09-15 2023-03-07 北京福元医药股份有限公司 一种贝达喹啉药物制剂
KR102478006B1 (ko) 2020-12-03 2022-12-15 정승찬 자동차 긴급 제동장치
GB202100470D0 (en) * 2021-01-14 2021-03-03 Summit Oxford Ltd Solid tablet dosage for of ridinilazole
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
GB202211231D0 (en) 2022-08-02 2022-09-14 Glaxosmithkline Ip No 2 Ltd Novel formulation
WO2024130214A2 (en) * 2022-12-17 2024-06-20 Via Therapeutics, Llc Clofazimine mini-tablets for treatment of tuberculosis in pediatrics

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4484703B2 (ja) 2002-07-25 2010-06-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キノリン誘導体およびミコバクテリア抑制剤としてのそれらの使用
KR20130024969A (ko) * 2004-05-28 2013-03-08 얀센 파마슈티카 엔.브이. 약물 내성 마이코박테리아 질환 치료를 위한 치환된 퀴놀린 유도체의 용도
EE05394B1 (et) 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
JP5410749B2 (ja) * 2005-05-25 2014-02-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ （アルファｓ，ベータｒ）−６−ブロモ−アルファ−［２−（ジメチルアミノ）エチル］−２−メトキシ−アルファ−１−ナフタレニル−ベータ−フェニル−３−キノリンエタノールの製造方法
EE05697B1 (et) * 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained
UY30535A1 (es) * 2006-08-10 2008-03-31 Cipla Ltd Composicion comprendiendo farmacos antirretrovirales y al menos un polimero insoluble en agua, proceso de preparacion y aplicaciones.
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
US20110159084A1 (en) * 2008-04-02 2011-06-30 Dr. Reddy's Laboratories Ltd. Raloxifene pharmaceutical formulations
CA2735229C (en) * 2008-09-03 2014-01-28 Pfizer Inc. Combination therapy for tuberculosis
US20120207838A1 (en) * 2011-02-10 2012-08-16 Perricone Nicholas V Treatment of Psoriasis Using Oral Dosage Forms of Nitrone Spin Traps
WO2013153162A1 (en) * 2012-04-11 2013-10-17 Sandoz Ag Polymorph of rilpivirine hydrochloride
US20140075692A1 (en) * 2012-09-18 2014-03-20 Unger Marketing International, Llc. Multiuse cleaning tool handle
JP2015537013A (ja) * 2012-11-19 2015-12-24 アサンタ・アー／エス 速崩性錠剤

Also Published As

Publication number Publication date
CY1126107T1 (el) 2023-11-15
AU2016212116A1 (en) 2017-07-27
DK3250182T3 (da) 2023-06-26
RS64308B1 (sr) 2023-07-31
EP3250182A1 (en) 2017-12-06
FI3250182T3 (fi) 2023-06-28
HUE062481T2 (hu) 2023-11-28
UA126891C2 (uk) 2023-02-22
CN114129526A (zh) 2022-03-04
PT3250182T (pt) 2023-07-07
CN107205945A (zh) 2017-09-26
HRP20230616T1 (hr) 2023-09-29
ES2948805T3 (es) 2023-09-19
BR112017015784A2 (pt) 2018-03-27
HK1243644A1 (zh) 2018-07-20
US20180000810A1 (en) 2018-01-04
JP7291458B2 (ja) 2023-06-15
JP2021098706A (ja) 2021-07-01
AU2016212116B2 (en) 2021-07-15
WO2016120258A1 (en) 2016-08-04
AU2021204135A1 (en) 2021-07-15
KR20170106447A (ko) 2017-09-20
MA41411A (fr) 2017-12-05
IL253626B2 (en) 2024-08-01
IL253626B1 (en) 2024-04-01
JP2018502928A (ja) 2018-02-01
JP2022176982A (ja) 2022-11-30
SG11201705944TA (en) 2017-08-30
LT3250182T (lt) 2023-07-10
KR102631986B1 (ko) 2024-01-30
EA201791701A1 (ru) 2017-11-30
SI3250182T1 (sl) 2023-08-31
PH12017501331A1 (en) 2017-12-11
IL310920A (en) 2024-04-01
PE20171319A1 (es) 2017-09-07
MD3250182T2 (ro) 2023-09-30
EP3250182B1 (en) 2023-04-26
MA41411B1 (fr) 2023-07-31
IL253626A0 (en) 2017-09-28
CA2973301A1 (en) 2016-08-04
AU2021204135B2 (en) 2023-10-05
PL3250182T3 (pl) 2023-07-31
US20220331307A1 (en) 2022-10-20

Similar Documents

Publication Publication Date Title
PH12017501331A1 (en) Dispersible compositions
EP3452597A4 (en) METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS
MX2017001279A (es) Usos y composiciones de la flagelina.
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
MX360041B (es) Composiciones y metodos para el cuidado personal.
SG10201811454WA (en) Materials and methods for controlling infections
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
WO2014184677A3 (en) Eye care devices and methods
ZA201905431B (en) Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same
NZ745186A (en) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
MX2019011613A (es) Formulaciones de acido 1-amino-1-ciclopropanocarboxilico.
MX2019004767A (es) Composiciones dispersables.
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
MX2019003212A (es) Composiciones que comprenden tensioactivos especificos y altos niveles de glicerina.
MX2019010640A (es) Formas cristalinas de acido obeticolico.
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
PH12019500180A1 (en) Compositions for the treatment of pulmonary fibrosis
WO2017142368A3 (ko) 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물
MY182818A (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
EP3668511A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF FIBROSE
AU201716785S (en) juicer
IL261240B (en) Preparations useful in the prevention and/or treatment of inflammation and pain
AU365991S (en) Lectern